If the function of GPIHBP1 is disabled by either bi-allelic loss-of-function variants (50, 51) or by inhibitory autoantibodies (8) the affected individuals develop severe hypertriglyceridemia with a risk for life-threatening pancreatitis. Here, GPIHBP1 is linked to hypertriglyceridemia.